New Insights into the Clinical Implications of Yes-Associated Protein in Lung Cancer: Roles in Drug Resistance, Tumor Immunity, Autophagy, and Organoid Development.

Yoo, Geon; Park, Dongil; Kim, Yoonjoo; Chung, Chaeuk

Yoo, Geon; Park, Dongil; Kim, Yoonjoo; Chung, Chaeuk.

Afiliação

Yoo G; Clinical Research Division, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Chungcheongbuk-do, Korea.
Park D; Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Kim Y; Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Chung C; Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, Korea.

Cancers (Basel) ; 13(12)2021 Jun 20.

Article em En | MEDLINE | ID: mdl-34202980

Palavras-chave

EGFR-TKI; Hippo pathway; PD-L1; TAZ; YAP; autophagy; drug-resistance; lung cancer; organoid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article